Introduction: The coronavirus disease 2019 (COVID-19) pandemic has brought unprecedented challenges to global healthcare systems, with the respiratory system being predominantly affected. However, emerging evidence suggests that COVID-19 can also lead to various cardiovascular complications. This retrospective study aims to investigate the prevalence of cardiac manifestations in COVID-19 patients and its association with disease severity. Methods: We conducted a retrospective analysis of medical records from 350 patients admitted with COVID-19 infection at a tertiary care hospital between June 2020 and July 2022. Patients were categorized into severe and non-severe groups based on clinical, lab parameters. Various cardiac manifestations, including heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), and pulmonary embolism, were evaluated. Results: Our findings revealed a clear correlation between the severity of COVID-19 and the prevalence of cardiovascular complications. Heart failure was observed in 7.4% of patients, with a significantly higher incidence rate in the severe COVID-19 group (10.9% versus 2.7% in non-severe group, p < 0.01). Similarly, the overall incidence of cardiac arrhythmias was 7.1%, with a higher prevalence in the severe COVID-19 group (10.5% versus 2.7% in non-severe group, p < 0.01). Myocarditis and ACS were reported in 6.6% and 10.3% of patients, respectively, with significantly higher rates in severe COVID-19 cases (p < 0.01). Additionally, pulmonary embolism was identified in 1.4% of patients, predominantly in the severe COVID-19 group (p < 0.01). Conclusion: Our study provides valuable insights into the diverse cardiac complications associated with COVID-19. The findings underscore the importance of vigilance among clinicians to recognize and manage these manifestations, particularly in severe cases. By understanding the impact of COVID-19 on cardiovascular health, healthcare providers can take proactive measures to optimize patient outcomes. Further research is needed to explore the underlying mechanisms and develop targeted interventions for these cardiac complications.

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has brought unprecedented challenges to global healthcare systems, with the respiratory system being predominantly affected. However, emerging evidence suggests that COVID-19 can also lead to various cardiovascular complications. This retrospective study aims to investigate the prevalence of cardiac manifestations in COVID-19 patients and its association with disease severity. Methods: We conducted a retrospective analysis of medical records from 350 patients admitted with COVID-19 infection at a tertiary care hospital between June 2020 and July 2022. Patients were categorized into severe and non-severe groups based on clinical, lab parameters. Various cardiac manifestations, including heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), and pulmonary embolism, were evaluated. Results: Our findings revealed a clear correlation between the severity of COVID-19 and the prevalence of cardiovascular complications. Heart failure was observed in 7.4% of patients, with a significantly higher incidence rate in the severe COVID-19 group (10.9% versus 2.7% in non-severe group, p < 0.01). Similarly, the overall incidence of cardiac arrhythmias was 7.1%, with a higher prevalence in the severe COVID-19 group (10.5% versus 2.7% in non-severe group, p < 0.01). Myocarditis and ACS were reported in 6.6% and 10.3% of patients, respectively, with significantly higher rates in severe COVID-19 cases (p < 0.01). Additionally, pulmonary embolism was identified in 1.4% of patients, predominantly in the severe COVID-19 group (p < 0.01). Conclusion: Our study provides valuable insights into the diverse cardiac complications associated with COVID-19. The findings underscore the importance of vigilance among clinicians to recognize and manage these manifestations, particularly in severe cases. By understanding the impact of COVID-19 on cardiovascular health, healthcare providers can take proactive measures to optimize patient outcomes. Further research is needed to explore the underlying mechanisms and develop targeted interventions for these cardiac complications.